Acute Lymphoblastic Leukaemia Ponatinib - Initial PBS Authority application Supporting information form (PB169)

Use this form for a patient starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with ponatinib for acute lymphoblastic leukaemia.


Page last updated: 5 February 2016

This information was printed Thursday 29 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.